Results 141 to 150 of about 277,312 (326)

Allergic conjunctivitis in Asia [PDF]

open access: yesAsia Pacific Allergy, 2017
Allergic conjunctivitis (AC), which may be acute or chronic, is associated with rhinitis in 30%-70% of affected individuals, hence the term allergic rhinoconjunctivitis (AR/C). Seasonal and perennial AC is generally milder than the more chronic and persistent atopic and vernal keratoconjunctivitis.
openaire   +2 more sources

Impact of socioeconomic and environmental factors on atopic eczema and allergic rhinitis: a cross sectional study [PDF]

open access: yes, 2015
The prevalence of allergic rhinitis and atopic eczema is on the rise in recent decades. Many factors can be related to the development of these diseases.
Bitarafan, Niloofar   +2 more
core   +1 more source

Immunomodulatory Effects of Galectin-1 on an IgE-Mediated Allergic Conjunctivitis Model [PDF]

open access: hybrid, 2015
C.B. Mello   +5 more
openalex   +1 more source

Ocular Microbiome in Dupilumab‐Induced Ocular Surface Disease

open access: yes
Allergy, EarlyView.
Andrea Leonardi   +4 more
wiley   +1 more source

Long‐term safety and efficacy of secukinumab in paediatric severe plaque psoriasis: 236‐week, Phase 3 trial results

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In this Phase III study, secukinumab demonstrated sustained efficacy and a favourable safety profile in paediatric patients with chronic severe plaque psoriasis over a treatment period of 236 weeks. Abstract Background Plaque psoriasis, a chronic inflammatory disease, affects up to 2.1% of the global paediatric population.
Andrzej Kaszuba   +11 more
wiley   +1 more source

Efficacy of up to 4 years of tralokinumab in adults with moderate‐to‐severe atopic dermatitis

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
AD is a relapsing and remitting skin disease often requiring long‐term treatment. We assessed the long‐term efficacy of tralokinumab in adults with moderate‐to‐severe AD consistently treated for up to 4 years. Treatment with tralokinumab plus optional TCS/TCI provided substantial improvements in AD signs and symptoms, and these improvements were ...
Melinda Gooderham   +13 more
wiley   +1 more source

Sleep and Trajectories of Respiratory and Allergic Symptoms Between 1 and 5.5 Years of Age in the Elfe Birth Cohort

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Sleep troubles and respiratory and allergic health issues are associated in children, but the timeline of their association is overlooked. This study investigates the associations between sleep patterns at age 1 and respiratory and allergic multi‐trajectories (RespA‐MTG) between ages 1 and 5.5, and the associations between these multi ...
Daniele Saade   +10 more
wiley   +1 more source

IL‐27 signaling deficiency develops Th17‐enhanced Th2‐dominant inflammation in murine allergic conjunctivitis model

open access: yesAllergy. European Journal of Allergy and Clinical Immunology, 2019
While most studies focus on pro‐allergic cytokines, the protective role of immunosuppressive cytokines in allergic inflammation is not well elucidated. This study was to explore a novel anti‐inflammatory role and cellular/molecular mechanism of IL‐27 in ...
Xin Chen   +10 more
semanticscholar   +1 more source

A combination of modified Kuhnt–Szymanowski and Celsus–Hotz techniques for correction of entropion and overlong lower eyelids in dogs (40 eyes)

open access: yesVeterinary Ophthalmology, Volume 28, Issue 2, Page 114-123, March 2025.
Abstract Purpose To describe a surgical approach to correct entropion and overlong lower eyelids in dogs by combining the Celsus–Hotz with the modified Kuhnt–Szymanowski technique. Methods Medical records of patients undergoing the described surgical procedure were reviewed.
Hanna Walter   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy